TP53 and nonpapillary renal cell carcinoma: In ccRCC, p53 was reported to be rarely mutated and functionally inhibited, and p53 status does not dictate HIF2α dependence in preclinical models [38, 39], indicating that USP7 depletion may suppress ccRCC cell proliferation independent of the MDM2-p53 pathway.